ABEO News and Press, Abeona Therapeutics Inc.

CLEVELAND, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On January 31, 2026, the Co...

CLEVELAND, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Mohamad Tabrizi, M.S., M.B.A., as Senior Vice President, Chief Business Officer (CBO). In this role, Mr. Tabrizi will lead the Company’s corporate strategy and business d...

CLEVELAND, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in Galveston, Texas, as the newest Qualified Treatment Center (QTC) for the administration of ZEVASKYN (prademagene zamikeracel) gene-mo...

CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the first commercial patient treatment with FDA-approved ZEVASKYN (prademagene zamikeracel), a first-of-its-kind, autologous gene therapy for treating wounds in adult and pediatric patients with r...

2025-11-12 15:50:17 ET DENVER, Colo., Nov 12, 2025 ( 247marketnews.com )- The final trading hour of Wednesday’s session is shaping up to be a sprint to the finish line as investors pile into biotech, AI, and clean-tech names on strong earnings, corporate catalysts, and heavy...

2025-11-12 14:52:18 ET Thesis Abeona Therapeutics Inc. ( ABEO ) reported some pretty attractive figures for 3Q25, and the stock is already up 22% post announcement. GAAP EPS came in at just -$0.10, beating expectations by $0.18. The company also ended the quarter with a heft...

2025-11-12 12:12:39 ET More on Abeona Therapeutics Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript Abeona Therapeutics: Zevaskyn Data Key In Gauging Momentum - Why I Hold Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript Abeona...

2025-11-12 12:11:36 ET Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST... Read the full article on Seeking Alpha For further details see: Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript

2025-11-12 11:37:50 ET Abeona Therapeutics (NASDAQ: ABEO) stock soared by more than 25% as of 10 a.m. today. The reason for the surging share price is a strong set of third-quarter earnings and a very positive update on its Recessive Dystrophic Epidermolysis Bullosa (RDEB) treatment...

2025-11-12 07:33:36 ET More on Abeona Therapeutics Abeona Therapeutics: Zevaskyn Data Key In Gauging Momentum - Why I Hold Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript Abeona Therapeutics: AAV204 Capsid Could Be Next Growth Prospect Beyond Zevasky...